Featured Products

My Quote Request

No products added yet

6505-01-304-9761

20 Products

NDC24208-0505-05

LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP

NSN, MFG P/N

6505013049761

NSN

6505-01-304-9761

View More Info

NDC24208-0505-05

LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP

NSN, MFG P/N

6505013049761

NSN

6505-01-304-9761

MFG

BAUSCH & LOMB PHARMACEUTICALS DIV BAUSCH & LOMB PHAMACEUTICAL

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V LEVOBUNOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION USP 5ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
SPECIAL FEATURES: W/QD (ONCE A DAY) COMPLIANCE CAP

NDC11980-0252-65

LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP

NSN, MFG P/N

6505013049761

NSN

6505-01-304-9761

View More Info

NDC11980-0252-65

LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP

NSN, MFG P/N

6505013049761

NSN

6505-01-304-9761

MFG

ALLERGAN INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V LEVOBUNOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION USP 5ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
SPECIAL FEATURES: W/QD (ONCE A DAY) COMPLIANCE CAP

CEFADYL

CEPHAPIRIN SODIUM,USP

NSN, MFG P/N

6505013050461

NSN

6505-01-305-0461

View More Info

CEFADYL

CEPHAPIRIN SODIUM,USP

NSN, MFG P/N

6505013050461

NSN

6505-01-305-0461

MFG

BRISTOL-MYERS SQUIBB PHARMACEUTICAL CO APOTHECON DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEPHAPIRIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML. I.V. PIGGYBACK VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00015-7628-22

CEPHAPIRIN SODIUM,USP

NSN, MFG P/N

6505013050461

NSN

6505-01-305-0461

View More Info

NDC00015-7628-22

CEPHAPIRIN SODIUM,USP

NSN, MFG P/N

6505013050461

NSN

6505-01-305-0461

MFG

BRISTOL-MYERS SQUIBB PHARMACEUTICAL CO APOTHECON DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEPHAPIRIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML. I.V. PIGGYBACK VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC49452-4050-02

LIDOCAINE HYDROCHLORIDE,USP

NSN, MFG P/N

6505013051166

NSN

6505-01-305-1166

View More Info

NDC49452-4050-02

LIDOCAINE HYDROCHLORIDE,USP

NSN, MFG P/N

6505013051166

NSN

6505-01-305-1166

MFG

SPECTRUM LABORATORY PRODUCTS INC. DBA SPECTRUM CHEMICALS AND LABORATORY PRODUCTS

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIDOCAINE HYDROCHLORIDE USP POWDER FORM 100GM BT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SPECTRUM CHEMICAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE

NDC58406-0623-07

LEUCOVORIN CALCIUM FOR INJECTION

NSN, MFG P/N

6505013051167

NSN

6505-01-305-1167

View More Info

NDC58406-0623-07

LEUCOVORIN CALCIUM FOR INJECTION

NSN, MFG P/N

6505013051167

NSN

6505-01-305-1167

MFG

AMGEN INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 350.000 MILLIGRAMS LEUCOVORIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEUCOVORIN CALCIUM FOR INJECTION 350MG VIAL
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 350.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL

F89E508

MAGNESIUM CITRATE ORAL SOLUTION,USP

NSN, MFG P/N

6505013051170

NSN

6505-01-305-1170

View More Info

F89E508

MAGNESIUM CITRATE ORAL SOLUTION,USP

NSN, MFG P/N

6505013051170

NSN

6505-01-305-1170

MFG

AIR FORCE MEDICAL LOGISTICS OFFICE

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM CITRATE ORAL SOLUTION USP 10FL OZ BT 12S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HUMCO/WALMEAD
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS OR 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC00395-0600-10

MAGNESIUM CITRATE ORAL SOLUTION,USP

NSN, MFG P/N

6505013051170

NSN

6505-01-305-1170

View More Info

NDC00395-0600-10

MAGNESIUM CITRATE ORAL SOLUTION,USP

NSN, MFG P/N

6505013051170

NSN

6505-01-305-1170

MFG

AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM CITRATE ORAL SOLUTION USP 10FL OZ BT 12S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HUMCO/WALMEAD
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS OR 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC00869-0693-38

MAGNESIUM CITRATE ORAL SOLUTION,USP

NSN, MFG P/N

6505013051170

NSN

6505-01-305-1170

View More Info

NDC00869-0693-38

MAGNESIUM CITRATE ORAL SOLUTION,USP

NSN, MFG P/N

6505013051170

NSN

6505-01-305-1170

MFG

AARON LABS

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM CITRATE ORAL SOLUTION USP 10FL OZ BT 12S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HUMCO/WALMEAD
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS OR 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC87701-0402-44

MAGNESIUM CITRATE ORAL SOLUTION,USP

NSN, MFG P/N

6505013051170

NSN

6505-01-305-1170

View More Info

NDC87701-0402-44

MAGNESIUM CITRATE ORAL SOLUTION,USP

NSN, MFG P/N

6505013051170

NSN

6505-01-305-1170

MFG

AARON INDUSTRIES INC DBA BUILDERS LUMBER AND SUPPLY

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM CITRATE ORAL SOLUTION USP 10FL OZ BT 12S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HUMCO/WALMEAD
PRIMARY CONTAINER CONTENT QUANTITY: 300.000 MILLILITERS OR 10.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12

0332-56

ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP

NSN, MFG P/N

6505013053136

NSN

6505-01-305-3136

View More Info

0332-56

ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP

NSN, MFG P/N

6505013053136

NSN

6505-01-305-3136

MFG

AVENTIS PHARMACEUTICALS PRODUCTS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 225.000 MILLIGRAMS ALUMINUM HYDROXIDE PER 5 MILLILITERS AND 200.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER 5 MILLILITERS AND 25.000 MILLIGRAMS SIMETHICONE PER 5 MILLILITERS
ADMINISTRATION: ORAL
FEATURES PROVIDED: UNIT DOSE
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SODIUM-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 100

MAALOX PLUS SUSP

ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP

NSN, MFG P/N

6505013053136

NSN

6505-01-305-3136

View More Info

MAALOX PLUS SUSP

ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP

NSN, MFG P/N

6505013053136

NSN

6505-01-305-3136

MFG

AVENTIS PHARMACEUTICALS PRODUCTS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 225.000 MILLIGRAMS ALUMINUM HYDROXIDE PER 5 MILLILITERS AND 200.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER 5 MILLILITERS AND 25.000 MILLIGRAMS SIMETHICONE PER 5 MILLILITERS
ADMINISTRATION: ORAL
FEATURES PROVIDED: UNIT DOSE
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SODIUM-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 100

NDC00067-0332-22

ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP

NSN, MFG P/N

6505013053136

NSN

6505-01-305-3136

View More Info

NDC00067-0332-22

ALUMINA,MAGNESIA,AND SIMETHICONE ORAL SUSPENSION,USP

NSN, MFG P/N

6505013053136

NSN

6505-01-305-3136

MFG

AVENTIS PHARMACEUTICALS PRODUCTS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 225.000 MILLIGRAMS ALUMINUM HYDROXIDE PER 5 MILLILITERS AND 200.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER 5 MILLILITERS AND 25.000 MILLIGRAMS SIMETHICONE PER 5 MILLILITERS
ADMINISTRATION: ORAL
FEATURES PROVIDED: UNIT DOSE
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SODIUM-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 100

NDC00054-4657-25

OXYCODONE HYDROCHLO

NSN, MFG P/N

6505013053145

NSN

6505-01-305-3145

View More Info

NDC00054-4657-25

OXYCODONE HYDROCHLO

NSN, MFG P/N

6505013053145

NSN

6505-01-305-3145

MFG

BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG.; 100 TABLETS PER BOTTLE

ROXICODONE

OXYCODONE HYDROCHLO

NSN, MFG P/N

6505013053145

NSN

6505-01-305-3145

View More Info

ROXICODONE

OXYCODONE HYDROCHLO

NSN, MFG P/N

6505013053145

NSN

6505-01-305-3145

MFG

BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG.; 100 TABLETS PER BOTTLE

NDC00078-0078-05

NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505013054523

NSN

6505-01-305-4523

View More Info

NDC00078-0078-05

NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505013054523

NSN

6505-01-305-4523

MFG

NOVARTIS PHARMACEUTICALS CORPORATION

Description

CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORTRIPTYLINE HYDROCHLORIDE CAPSULES USP 50MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 50.000 MG NORTRIPTYLINE EQUIVALENT
THERAPEUTIC EQUIVALENT: PAMELOR BY SANDOZ PHARMACEUTICALS

PAMELOR

NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505013054523

NSN

6505-01-305-4523

View More Info

PAMELOR

NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505013054523

NSN

6505-01-305-4523

MFG

NOVARTIS PHARMACEUTICALS CORPORATION

Description

CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORTRIPTYLINE HYDROCHLORIDE CAPSULES USP 50MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 50.000 MG NORTRIPTYLINE EQUIVALENT
THERAPEUTIC EQUIVALENT: PAMELOR BY SANDOZ PHARMACEUTICALS

NDC00026-0601-30

ALPHA-1-PROTEINASE INHIBITOR,HUMAN,STERILE

NSN, MFG P/N

6505013054683

NSN

6505-01-305-4683

View More Info

NDC00026-0601-30

ALPHA-1-PROTEINASE INHIBITOR,HUMAN,STERILE

NSN, MFG P/N

6505013054683

NSN

6505-01-305-4683

MFG

TALECRIS BIOTHERAPEUTICS INC.

Description

FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALPHA-1-PROTEINASE INHIBITOR HUMAN STERILE 500MG VIAL PG
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE-FREE; WITH 20 ML VIAL STERILE WATER FOR INJECTION,USP,STERILE DOUBLE-ENDED TRANSFER NEEDLE,AND STERILE FILTER NEEDLE

NDC00006-3508-04

ENALAPRILAT INJECTION

NSN, MFG P/N

6505013056988

NSN

6505-01-305-6988

View More Info

NDC00006-3508-04

ENALAPRILAT INJECTION

NSN, MFG P/N

6505013056988

NSN

6505-01-305-6988

MFG

MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.250 MILLIGRAMS ENALAPRILAT,ANHYDROUS PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ENALAPRILAT INJECTION 1.25MG ANHYDROUS ENALAPRILAT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.250 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL

NDC00074-2122-02

ENALAPRILAT INJECTION

NSN, MFG P/N

6505013056988

NSN

6505-01-305-6988

View More Info

NDC00074-2122-02

ENALAPRILAT INJECTION

NSN, MFG P/N

6505013056988

NSN

6505-01-305-6988

MFG

ABBOTT LABORATORIES INC ROSS PRODUCTS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.250 MILLIGRAMS ENALAPRILAT,ANHYDROUS PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ENALAPRILAT INJECTION 1.25MG ANHYDROUS ENALAPRILAT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.250 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL